PI4K: A Promising Drug Target for Various Diseases (P23955)

Target Name: Phosphatidylinositol 4-Kinase (PI4K)

NCBI ID: P23955

Phosphatidylinositol 4-Kinase (PI4K)

Other Name(s): Phosphatidylinositol 4-Kinase (PI4K)

PI4K: A Promising Drug Target for Various Diseases

Phosphatidylinositol 4-kinase (PI4K) is a protein that is involved in various cellular processes in the cell. It is a key enzyme in the PI4K signaling pathway, which is a well-established signaling pathway that plays a role in various cellular processes, including cell signaling, cell survival, and cell division. PI4K is a protein that is expressed in many different cell types, including neurons, and it is involved in the regulation of various cellular processes, including cell signaling, cell survival, and cell division.

One of the things that makes PI4K an attractive drug target is its role in cell signaling. PI4K is involved in the regulation of many different signaling pathways, including the PI3K/Akt signaling pathway, the TOR signaling pathway, and the NF-kappa-B signaling pathway . These signaling pathways are involved in the regulation of various cellular processes, including cell signaling, cell survival, and cell division. By targeting PI4K, researchers can gain insights into these signaling pathways and potentially develop new treatments for a variety of diseases.

Another reason why PI4K is an attractive drug target is its role in cell survival. PI4K is involved in the regulation of various cellular processes that are necessary for cell survival, including the regulation of cell death and the regulation of cell proliferation. Research shows that PI4K is involved in the regulation of cell death, and that targeting it may be an effective way to treat certain forms of cancer. Additionally, PI4K is involved in the regulation of cell proliferation, and that targeting it may be an effective way to treat certain forms of cancer. of cancer, including breast cancer.

In addition to its role in cell signaling and cell survival, PI4K is also involved in the regulation of cell division. Research shows that PI4K is involved in the regulation of mitosis, which is the process by which a cell divides. regulation of mitosis and targeting that it may be an effective way to treat certain forms of cancer.

Another potential drug target for PI4K is its role in the regulation of inflammation. PI4K is involved in the regulation of various cellular processes that are involved in inflammation, including the regulation of pain and the regulation of inflammation. Studies have shown that PI4K is involved in the Regulation of pain and that targeting it may be an effective way to treat certain forms of pain. Additionally, PI4K is involved in the regulation of inflammation, and that targeting it may be an effective way to treat certain forms of inflammation, including autoimmune diseases.

In conclusion, PI4K is an attractive drug target due to its role in cell signaling, cell survival, and cell division. It is involved in the regulation of various cellular processes, including cell signaling, cell survival, and cell division, and targeting it may be an way to treat a variety of diseases. Additionally, PI4K is also involved in the effective regulation of inflammation, which may be an attractive target for future research. Further research is needed to fully understand the role of PI4K in these processes and to identify potential drug targets.

Protein Name: Phosphatidylinositol 4-Kinase (PI4K) (nonspecified Subtype)

The "Phosphatidylinositol 4-Kinase (PI4K) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Phosphatidylinositol 4-Kinase (PI4K) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets